Literature DB >> 12121050

Are antiphospholipid antibodies an independent risk factor for atherosclerosis?

Franca Bilora1, Veronica Boccioletti, Bruno Girolami, Ezio Zanon, Mario Armani, Francesco Petrobelli, Antonio Girolami.   

Abstract

The purpose of this study was to check whether antiphospholipid antibodies (aPL) could be an independent risk factor for atherosclerosis. Eighty-five subjects were studied: 45 with primitive antiphospholipid antibody syndrome and 40 controls affected by deep vein thrombosis secondary to known causes. The two groups were homogeneous for age, sex, and risk factors for atherosclerosis. All the subjects submitted to echo-color doppler of the carotid arteries, femoral arteries, and abdominal aorta. The cases were then subdivided into three subgroups on the basis of the positivity to the three subpopulations of aPL. Results demonstrate that there is no correlation between aPL and atherosclerosis. The different positivity to aPL does not modify this conclusion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121050     DOI: 10.1177/107602960200800205

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  7 in total

1.  Impaired ankle-brachial index in antiphospholipid syndrome: Beyond the traditional risk factors.

Authors:  Simona Caraiola; Ciprian Jurcut; Alina Dima; Ruxandra Jurcut; Cristian Baicus; Anda Baicus
Journal:  J Clin Lab Anal       Date:  2018-07-10       Impact factor: 2.352

2.  Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey.

Authors:  Ömer Uludağ; Murat Bektaş; Erhan Çene; Murat Sezer; Yasemin Şahinkaya; Ahmet Gül; Murat Inanç; Lale Öcal; Bahar Artim-Esen
Journal:  J Thromb Thrombolysis       Date:  2021-02       Impact factor: 2.300

Review 3.  Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome.

Authors:  Roberta Gualtierotti; Martina Biggioggero; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

Review 4.  Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome.

Authors:  Paul R J Ames; Annamaria Margarita; Jose Delgado Alves
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

Review 5.  Cardiovascular risk factors in the antiphospholipid syndrome.

Authors:  Felipe Freire da Silva; Roger Abramino Levy; Jozélio Freire de Carvalho
Journal:  J Immunol Res       Date:  2014-07-13       Impact factor: 4.818

6.  Aortic Atherosclerosis in Systemic Lupus Erythematosus.

Authors:  Paola C Roldan; Michelle Ratliff; Richard Snider; Leonardo Macias; Rodrigo Rodriguez; Wilmer Sibbitt; Carlos A Roldan
Journal:  Rheumatology (Sunnyvale)       Date:  2014

Review 7.  Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form.

Authors:  Tamara Kolitz; Shachaf Shiber; Itzhak Sharabi; Asher Winder; Gisele Zandman-Goddard
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.